Go to deals
Private Equity | Healthcare

Converge International receives investment from the Victorian Business Growth Fund

Converge International has raised funds from the Victorian Business Growth Fund. The investment was managed by ROC Partners and the capital raised will be used to fund the acquisition of HeadUp Labs and support future growth.

Converge is Australia’s most established B2B workplace mental health and wellbeing service provider, enabling corporate and government organizations to provide their employees with the wellbeing support they need, reducing risk, improving employee resilience and increasing workforce participation.

Oaklins’ team in Australia advised Converge International on their investment from the Victorian Business Growth Fund.

“From the commencement of the engagement with Oaklins, we were delighted by the speed with which they were able to grasp Converge’s vision and strategy, understand and provide advice on the ‘buy’ vs ‘build’ options and identify highly synergistic value-adding acquisition opportunities, the best sources of capital, and act on behalf of Converge to progressively finetune the approaches and support the buy-side and investor negotiations. At all times the team provided Converge with advice that was proactive, wise, and transparent. It has been a genuine partnership which we look forward to continuing with them as we seek further M&A opportunities to support our growth.”

Terry Winters

Chairman, Converge International

Talk to the deal team

Scott McInnes

Managing Director
Melbourne, Australia
Oaklins Henslow

Related deals

Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Private Equity | Logistics

Sun European Partners has secured financing to support its acquisition of B&H Worldwide

Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.

Learn more
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Private Equity | Business Support Services | Construction & Engineering Services

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.

Learn more